Key result
Syrian refugee children with heart disease face ~14% mortality and frequent failure to thrive.
Why the study?
Demand for health care was overwhelming among Syrian refugees in Jordan, but the burden of heart disease in Syrian refugee children was not known.
Observational (n=119)
No
Syrian refugee children with heart disease face high mortality and severe delays in surgical treatment due to lack of funding and resources.
Answers are grounded in this paper and cite their sources.
Emphasizes high morbidity and mortality in displaced children; observational data leaves open scalable models for timely cardiac care.
BACKGROUND: Since March 2011, an estimated 600,000 Syrian refugees crossed into Jordan, of which 52% were children. Demand for health care is overwhelming. The burden of heart disease in Syrian refugee children is not known. The aim of this study WAS to describe heart disease in Syrian refugee children in terms of diagnoses, presentation, outcome, and funding sources for treatment. METHODS: From April 1, 2012 to April 30, 2014, data on Syrian refugee children who were referred to the Pediatric Cardiology Department at Jordan University Hospital and were found to have heart disease was recorded. In this study, we describe diagnoses, presentations, complications, and mortality. We discuss therapeutic procedures and their funding sources. Patients were followed until July 31, 2014. FINDINGS: In all, 119 children, median age 2 years (6 days to 16 years), were diagnosed with heart disease. At presentation, 37% had failure to thrive, 13% had severe complications, and 32% of cyanotic patients had severe hypoxia with oxygen saturation of <70%. Mortality rate was 14% by end of follow up. Of 73 surgical procedures recommended, only 28 were funded and performed; others have been waiting for a median of 223 days (35-534 days). Funding for procedures came from multiple sources; including the United Nations, governmental and nongovernmental organizations, and individual donations. CONCLUSION: Heart disease in Syrian refugee children constitutes a major problem for both patients and health systems of host countries. Late presentation and diagnosis, high rate of complications, suboptimal living conditions, lack of funding, shortage of specialized centers and personnel, and high mortality rates are among the major challenges facing this patient population.
No takes yet. Share an insight, caveat, or question.
Al‐Ammouri et al. (2016) conducted an observational in Heart disease (congenital and acquired) (n=119). Syrian refugee status was evaluated on Mortality rate by end of follow-up. Among 119 Syrian refugee children with heart disease, 37% presented with failure to thrive, 13% had severe complications, and the mortality rate was 14% by the end of follow-up.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: